Cite
SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients.
MLA
Gozalbo-Rovira, Roberto, et al. “SARS-CoV-2 Antibodies, Serum Inflammatory Biomarkers and Clinical Severity of Hospitalized COVID-19 Patients.” Journal of Clinical Virology : The Official Publication of the Pan American Society for Clinical Virology, vol. 131, Oct. 2020, p. 104611. EBSCOhost, https://doi.org/10.1016/j.jcv.2020.104611.
APA
Gozalbo-Rovira, R., Gimenez, E., Latorre, V., Francés-Gómez, C., Albert, E., Buesa, J., Marina, A., Blasco, M. L., Signes-Costa, J., Rodríguez-Díaz, J., Geller, R., & Navarro, D. (2020). SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients. Journal of Clinical Virology : The Official Publication of the Pan American Society for Clinical Virology, 131, 104611. https://doi.org/10.1016/j.jcv.2020.104611
Chicago
Gozalbo-Rovira, Roberto, Estela Gimenez, Víctor Latorre, Clara Francés-Gómez, Eliseo Albert, Javier Buesa, Alberto Marina, et al. 2020. “SARS-CoV-2 Antibodies, Serum Inflammatory Biomarkers and Clinical Severity of Hospitalized COVID-19 Patients.” Journal of Clinical Virology : The Official Publication of the Pan American Society for Clinical Virology 131 (October): 104611. doi:10.1016/j.jcv.2020.104611.